449 THE BURDEN OF PRE-TREATMENT URINARY, SEXUAL, AND BOWEL DYSFUNCTION ACROSS TWO DECADES OF PROSTATE CANCER: RESULTS FROM PCOS AND CEASAR
Matthew J. Resnick(Vanderbilt University Medical Center), David F. Penson(Geriatric Research Education and Clinical Center), Richard M. Hoffman(University of Iowa), Amee Morgans(Nashville Oncology Associates), Vivien W. Chen(Louisiana State University Health Sciences Center New Orleans), Tatsuki Koyama(Vanderbilt University Medical Center), Sherrie H. Kaplan(University of California, Irvine), Daniel A. Barocas(Vanderbilt University Medical Center), Antoinette M. Stroup(Rutgers, The State University of New Jersey), Xiao‐Cheng Wu(London School of Hygiene & Tropical Medicine), Sharon Phillips(Vanderbilt University Medical Center), Matthew R. Cooperberg(University of California, San Francisco), Ann S. Hamilton(University of Southern California), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Janet L. Stanford(Fred Hutch Cancer Center), John Graff, Kang-Hsien Fan, Sheldon Greenfield(University of California, Irvine), Peter C. Albertsen(UConn Health)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656